Ryan Funk, MD
Otolaryngology · Appleton, WINPI 1720460363
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 49.4% of the total. Reporting peaked in 2020 at $300 and has fallen 77.4% since, to $68 in 2025.
Across 24 payments — averaging $48.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$580
- Acclarent, Inc$116
- Stryker$112
- Optinose US, Inc.$90
- Intersect ENT, Inc.$49
- Sanofi$49
- plus $177 from 7 others
What the payments were for
- Food & beverage$59451%
- Education$58049%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $580 |
| Acclarent, Inc | 3 | $116 |
| Stryker | 5 | $112 |
| Optinose US, Inc. | 4 | $90 |
| Intersect ENT, Inc. | 1 | $49 |
| Sanofi | 2 | $49 |
| Cochlear Americas | 1 | $47 |
| GSK | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Medtronic | 1 | $18 |
| CSL Behring | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $12 |
How this compares
$1,174 in reported general payments places this provider in the 70th percentile of 168 otolaryngology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 43 | $751 |
| Famotidine | 26 | $223 |
| Omeprazole | 21 | $173 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Appleton
- Rahul SubbarayanAppleton$2K
- Gregory SwansonAppleton$2K
- Jason BrantMadison$103K
- B WoodsonMilwaukee$45K
- Thomas Gessertla Crosse$21K
- Colleen PleinKenosha$16K
- Steven SperryGreenfield$13K
- David PoetkerMilwaukee$13K
- Michael OldenburgGreen Bay$8K
- Jamal AhmedMarshfield$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.